On 2024-03-07, Rapt Therapeutics (RAPT) announced earnings per share of $-0.80 for the fiscal quarter ending 2023-12-31, beating the average analyst estimate of $-0.85.
The next expected annoucement date for quarterly earnings is 2024-05-09, with an average estimated earnings per share of $-0.78 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-03-07 | 2023-12-31 | $-0.85 | $-0.80 |
| 2023-11-13 | 2023-09-30 | $-0.75 | $-0.82 |
| 2023-08-11 | 2023-06-30 | $-0.80 | $-0.66 |
| 2023-05-11 | 2023-03-31 | $-0.64 | $-0.76 |
| 2023-03-14 | 2022-12-31 | $-0.67 | $-0.64 |
| 2022-11-10 | 2022-09-30 | $-0.65 | $-0.63 |
| 2022-08-11 | 2022-06-30 | $-0.75 | $-0.62 |
| 2022-05-11 | 2022-03-31 | $-0.66 | $-0.69 |
| 2022-03-10 | 2021-12-31 | $-0.66 | $-0.61 |
| 2021-11-10 | 2021-09-30 | $-0.60 | $-0.63 |
| 2021-08-11 | 2021-06-30 | $-0.62 | $-0.63 |
| 2021-05-11 | 2021-03-31 | $-0.52 | $-0.66 |
| 2021-03-11 | 2020-12-31 | $-0.54 | $-0.52 |
| 2020-11-16 | 2020-09-30 | $-0.49 | $-0.60 |
| 2020-08-13 | 2020-06-30 | $-0.49 | $-0.51 |
| 2020-05-14 | 2020-03-31 | $-0.49 | $-0.56 |
| 2020-03-30 | 2019-12-31 | -- | $-0.87 |
| 2019-12-11 | 2019-09-30 | -- | $-12.41 |